CMS announced stronger safeguards and oversight measures for the organ donation and procurement system, with a stated focus on patient protections and accountability. The guidance-centered action indicates closer scrutiny of how organ procurement organizations operate and are monitored. The changes are intended to reinforce standards in a system with significant consequences for patients awaiting transplants and donor families.
